Who We Are

Cell-engineering and HTS assay experts in the Bay Area
to help make
“Better Medicine, One Assay at a Time"

Multispan, Inc. is a premier cell-engineering, assay development and compound screening company focusing on drug discovery targeting GPCRs and beyond. It has created the industry’s largest, highly characterized, high quality stable cell lines expressing GPCR, kinase and other target classes. The platform uniquely empowers lead identification and optimization for developing better medicine to treat cardiovascular, metabolic, neurodegenerative, depression, inflammation, immunology and oncology diseases.

Learning Is Power

MEETING THE NEED FOR ACCELERATED COVID ANTIVIRAL AND VACCINE DEVELOPMENT

The foundational role of relevant, robust cell-based assays in covid antiviral and vaccine development.

Don’t Let GPCR Tagging Bias Your Results

Harness the power of freeing your GPCR from unwanted tags using Multispan’s proprietary MultiScreen™ β-Arrestin sensor technology.

HIGH THROUGHPUT SCREENING DONE RIGHT

The Power of Integrating Screening and Assay Development.

GPCR MEMBRANE LIGAND BINDING ASSAYS THE CRITICAL ROLE OF CELL MEMBRANES

Explore the many types of ligand binding assays using GPCR membranes and the importance of high-quality membranes for assay development.

CRISPR: A NEW BREAK IN THE PIPELINE

CRISPR cell engineering solutions have seamless integration into Multispan’s full assay development, screening and profiling services for drug discovery.

BUILDING BETTER DRUGS

The role assay development plays in drug discovery.

STRATEGIES AND TOOLS TO DEVELOP A BETTER GPCR TARGETED THERAPEUTIC

>>

MULTISCREEN™ GPCR DIVISION-ARRESTED CELLS

Assay-Ready Cells For Same-Day Plate-And-Read >>


Testimonials